| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | TPR | 1.01e-05 | 129 | 151 | 8 | SM00028 | |
| Domain | TPR_repeat | 1.27e-05 | 133 | 151 | 8 | IPR019734 | |
| Domain | TPR-contain_dom | 3.03e-05 | 150 | 151 | 8 | IPR013026 | |
| Domain | - | 4.81e-05 | 207 | 151 | 9 | 1.25.40.10 | |
| Domain | TPR_REGION | 5.96e-05 | 165 | 151 | 8 | PS50293 | |
| Domain | TPR | 5.96e-05 | 165 | 151 | 8 | PS50005 | |
| Domain | TPR-like_helical_dom | 1.19e-04 | 233 | 151 | 9 | IPR011990 | |
| Domain | DUF2075 | 1.94e-04 | 3 | 151 | 2 | PF09848 | |
| Domain | DUF2075 | 1.94e-04 | 3 | 151 | 2 | IPR018647 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | JCAD FLNA DLG5 SPAG1 UBAP2 ZFYVE16 TTC7A DST KIAA1217 CCSER2 PLEKHA1 SPRED1 FSCN1 LRRFIP1 | 2.50e-07 | 565 | 154 | 14 | 25468996 |
| Pubmed | FNIP2 UNC13B ZHX3 ZFYVE16 FSTL5 POGZ TENM2 NAV3 TCF25 MCF2L TET3 PDZD2 | 3.02e-07 | 407 | 154 | 12 | 12693553 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 14593078 | ||
| Pubmed | Genome-wide association of lipid-lowering response to statins in combined study populations. | 8.39e-07 | 72 | 154 | 6 | 20339536 | |
| Pubmed | The actin-binding protein Filamin-A interacts with the metabotropic glutamate receptor type 7. | 1.69e-06 | 6 | 154 | 3 | 11943148 | |
| Pubmed | RGPD4 FLNA ZEB1 ZFYVE16 CENPF POGZ RLF DST RGPD3 ARID5B TMF1 | 2.86e-06 | 418 | 154 | 11 | 34709266 | |
| Pubmed | Dynamics of DNA hydroxymethylation and methylation during mouse embryonic and germline development. | 2.94e-06 | 7 | 154 | 3 | 36539615 | |
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 23238719 | ||
| Pubmed | RGPD4 JCAD GAD1 FLNA RAB35 UBAP2 RPS23 TENM2 RAB3GAP1 KIAA1217 RGPD3 PPA2 NAV3 TCF25 VARS1 NDRG4 LRRFIP1 AKAP7 | 3.26e-06 | 1139 | 154 | 18 | 36417873 | |
| Pubmed | 4.35e-06 | 25 | 154 | 4 | 29475039 | ||
| Pubmed | 4.69e-06 | 8 | 154 | 3 | 19619625 | ||
| Pubmed | 1.02e-05 | 167 | 154 | 7 | 22159717 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.22e-05 | 398 | 154 | 10 | 35016035 | |
| Pubmed | CCP110 FLNA PDE3A PMS2 CENPF TOPBP1 IFIT3 TMF1 UHRF1 TIMELESS LRRFIP1 | 1.63e-05 | 503 | 154 | 11 | 16964243 | |
| Pubmed | UNC13B BDP1 CCP110 FLNA RAB35 PMS2 SLFN5 ITGA2 HIBADH ZFX TMED3 CYREN MROH8 DST TAC3 TIMELESS AURKAIP1 SLFN11 | 1.82e-05 | 1293 | 154 | 18 | 15342556 | |
| Pubmed | Rab35 controls actin bundling by recruiting fascin as an effector protein. | 1.95e-05 | 2 | 154 | 2 | 19729655 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32488136 | ||
| Pubmed | Tandem orientation of the inter-alpha-trypsin inhibitor heavy chain H1 and H3 genes. | 1.95e-05 | 2 | 154 | 2 | 7522574 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 34260278 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 35034102 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24675808 | ||
| Pubmed | Human pre-alpha-trypsin inhibitor-precursor heavy chain. cDNA and deduced amino-acid sequence. | 1.95e-05 | 2 | 154 | 2 | 7681778 | |
| Pubmed | Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. | 1.95e-05 | 2 | 154 | 2 | 14756672 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19351574 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 26791531 | ||
| Pubmed | Association study of 44 candidate genes with depressive and anxiety symptoms in post-partum women. | 1.95e-05 | 2 | 154 | 2 | 20092830 | |
| Pubmed | 1.95e-05 | 334 | 154 | 9 | 30425250 | ||
| Pubmed | KIAA0408 FLNA CXorf38 NKX3-2 KCNK13 RPS23 ANKLE1 ITIH1 ANKRD54 FANCG KLHL36 AFP SLC17A8 PLEKHA1 | 2.16e-05 | 832 | 154 | 14 | 36724073 | |
| Pubmed | RGPD4 FLNA SPAG1 PCDHGB3 CENPF MYH7B SLC44A2 RPS23 MINDY2 ADAMTS12 DST SACS RGPD3 PHF14 PADI6 MCF2L USP1 DNAH6 VARS1 | 2.24e-05 | 1442 | 154 | 19 | 35575683 | |
| Pubmed | 2.29e-05 | 76 | 154 | 5 | 10574461 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 2.36e-05 | 13 | 154 | 3 | 20859245 | |
| Pubmed | 3.73e-05 | 15 | 154 | 3 | 20603015 | ||
| Pubmed | EHMT2 directs DNA methylation for efficient gene silencing in mouse embryos. | 3.73e-05 | 15 | 154 | 3 | 26576615 | |
| Pubmed | 5.15e-05 | 215 | 154 | 7 | 35973513 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 19332778 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 9756925 | ||
| Pubmed | Rab3GEP is the non-redundant guanine nucleotide exchange factor for Rab27a in melanocytes. | 5.83e-05 | 3 | 154 | 2 | 18559336 | |
| Pubmed | Resequencing three candidate genes for major depressive disorder in a Dutch cohort. | 5.83e-05 | 3 | 154 | 2 | 24278217 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 36351530 | ||
| Pubmed | Akt regulates the subcellular localization of the Rab27a-binding protein JFC1 by phosphorylation. | 5.83e-05 | 3 | 154 | 2 | 15998322 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 33068816 | ||
| Pubmed | Experimental validation of 5 in-silico predicted glioma biomarkers. | 5.83e-05 | 3 | 154 | 2 | 24158112 | |
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 9126497 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 8499653 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 9473604 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 2446322 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 7534067 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 11807786 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 2476436 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 36162459 | ||
| Pubmed | 5.83e-05 | 3 | 154 | 2 | 30556914 | ||
| Pubmed | UNC13B JCAD PMS2 ADAM19 USP11 GRIK1 POGZ ARMCX4 ANKRD54 UBE4A DST SACS ARID5B NAV3 SPRED1 VARS1 LRRFIP1 | 5.92e-05 | 1285 | 154 | 17 | 35914814 | |
| Pubmed | 6.86e-05 | 225 | 154 | 7 | 12168954 | ||
| Pubmed | 7.83e-05 | 19 | 154 | 3 | 33046550 | ||
| Pubmed | 7.96e-05 | 497 | 154 | 10 | 23414517 | ||
| Pubmed | 8.48e-05 | 52 | 154 | 4 | 9455477 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZHX3 TOPBP1 POGZ RLF UBN1 SCMH1 ATAD2B UHRF1 PHF14 TIMELESS CCDC86 | 9.00e-05 | 608 | 154 | 11 | 36089195 |
| Pubmed | Pet-1 is required across different stages of life to regulate serotonergic function. | 9.18e-05 | 20 | 154 | 3 | 20818386 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FLNA RAB35 ZEB1 UBAP2 RPS23 POGZ SLFN5 ITGA2 PLXNB2 RLF UBE4A ARID5B CCSER2 TIMELESS ATP1B3 RAB27A | 9.28e-05 | 1203 | 154 | 16 | 29180619 |
| Pubmed | 9.85e-05 | 103 | 154 | 5 | 10819331 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 11429708 | ||
| Pubmed | Distribution of group-III metabotropic glutamate receptors in the retina. | 1.16e-04 | 4 | 154 | 2 | 17311335 | |
| Pubmed | FANCD2 activates transcription of TAp63 and suppresses tumorigenesis. | 1.16e-04 | 4 | 154 | 2 | 23806336 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 10100603 | ||
| Pubmed | Human plasma inter-alpha-trypsin inhibitor is encoded by four genes on three chromosomes. | 1.16e-04 | 4 | 154 | 2 | 2465147 | |
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 18266782 | ||
| Pubmed | 1.16e-04 | 4 | 154 | 2 | 16004602 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.61e-04 | 24 | 154 | 3 | 35746896 | |
| Pubmed | 1.69e-04 | 62 | 154 | 4 | 19367581 | ||
| Pubmed | 1.82e-04 | 25 | 154 | 3 | 37493331 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 1.87e-04 | 118 | 154 | 5 | 19156168 | |
| Pubmed | Human adolescent nephronophthisis: gene locus synteny with polycystic kidney disease in pcy mice. | 1.93e-04 | 5 | 154 | 2 | 11134256 | |
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 18355440 | ||
| Pubmed | The interaction of DNA mismatch repair proteins with human exonuclease I. | 1.93e-04 | 5 | 154 | 2 | 11427529 | |
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 24089532 | ||
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 16873769 | ||
| Pubmed | Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype. | 1.93e-04 | 5 | 154 | 2 | 24043286 | |
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 1385302 | ||
| Pubmed | Regulation of stress-induced sleep perturbations by dorsal raphe VGLUT3 neurons in male mice. | 1.93e-04 | 5 | 154 | 2 | 38944834 | |
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 29528433 | ||
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 14676842 | ||
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 19015241 | ||
| Pubmed | 1.93e-04 | 5 | 154 | 2 | 23512250 | ||
| Pubmed | The genes for the inter-alpha-inhibitor family share a homologous organization in human and mouse. | 1.93e-04 | 5 | 154 | 2 | 1371941 | |
| Pubmed | 2.30e-04 | 27 | 154 | 3 | 27789623 | ||
| Pubmed | 2.30e-04 | 27 | 154 | 3 | 20080794 | ||
| Pubmed | Gene knockouts that cause female infertility: search for novel contraceptive targets. | 2.57e-04 | 28 | 154 | 3 | 15970507 | |
| Pubmed | 2.87e-04 | 376 | 154 | 8 | 24154525 | ||
| Pubmed | Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. | 2.89e-04 | 6 | 154 | 2 | 16144832 | |
| Pubmed | 2.89e-04 | 6 | 154 | 2 | 12546819 | ||
| Pubmed | 2.89e-04 | 6 | 154 | 2 | 22411829 | ||
| Pubmed | Schlafen, a new family of growth regulatory genes that affect thymocyte development. | 2.89e-04 | 6 | 154 | 2 | 9846487 | |
| Pubmed | Expression of GAD67 and Dlx5 in the taste buds of mice genetically lacking Mash1. | 2.89e-04 | 6 | 154 | 2 | 24682237 | |
| Pubmed | Thalamus mediates neocortical Down state transition via GABAB-receptor-targeting interneurons. | 2.89e-04 | 6 | 154 | 2 | 34314698 | |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 2.93e-04 | 130 | 154 | 5 | 19874574 | |
| Pubmed | 3.13e-04 | 288 | 154 | 7 | 38496616 | ||
| Pubmed | 3.49e-04 | 31 | 154 | 3 | 23312518 | ||
| Pubmed | 3.49e-04 | 31 | 154 | 3 | 19690177 | ||
| Pubmed | 3.71e-04 | 493 | 154 | 9 | 15368895 | ||
| Pubmed | RGPD4 ZEB1 UBAP2 CENPF ARMCX4 GRM4 TENM2 ITIH1 DST KIAA1217 RGPD3 FSCN1 LRRFIP1 | 3.75e-04 | 963 | 154 | 13 | 28671696 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.76e-05 | 115 | 102 | 6 | 769 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.44e-05 | 181 | 102 | 7 | 694 | |
| GeneFamily | Schlafen family | 6.50e-04 | 7 | 102 | 2 | 1110 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 8.63e-04 | 8 | 102 | 2 | 281 | |
| Coexpression | GSE42724_NAIVE_VS_MEMORY_BCELL_UP | 2.99e-06 | 200 | 154 | 9 | M9792 | |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR | 1.04e-05 | 84 | 154 | 6 | M2606 | |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR | 1.04e-05 | 127 | 154 | 7 | M2608 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 ZEB1 ZFYVE16 CENPF TOPBP1 ARFGEF1 RLF RAB3GAP1 DST SACS ATAD2B ARID5B CCSER2 NAV3 PHF14 SUCO LRRFIP1 | 1.23e-05 | 856 | 154 | 17 | M4500 |
| Coexpression | GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN | 2.52e-05 | 200 | 154 | 8 | M8327 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LPS_UP | LAMA3 SLFN5 PPP1R15A IFIT3 ZFX NLRP14 SPON1 NCOA7 DMRTB1 MCF2L FSCN1 | 2.99e-05 | 406 | 154 | 11 | M9673 |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 3.11e-05 | 206 | 154 | 8 | M14134 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | JCAD FLNA PDE3A ZEB1 ADAM19 RPS23 ITGA2 ADH5 SACS SPON1 ARID5B SPRED1 FSCN1 ATP1B3 | 5.20e-05 | 681 | 154 | 14 | M39175 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 ZEB1 SLFN5 RGPD3 NCOA7 SPRED1 SLFN11 NOCT MCF2L FSCN1 LRRFIP1 | 5.57e-05 | 435 | 154 | 11 | MM1221 |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | UNC13B JCAD SLC44A2 SLC6A4 DST HPGD KIAA1217 PLEKHA1 FSCN1 NDRG4 | 2.02e-09 | 199 | 154 | 10 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | UNC13B JCAD ZEB1 MINDY2 FAM13B IFIT3 SLC6A4 HPGD KIAA1217 DISP1 | 2.12e-09 | 200 | 154 | 10 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.12e-09 | 200 | 154 | 10 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 2.12e-09 | 200 | 154 | 10 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-08 | 177 | 154 | 9 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.92e-08 | 187 | 154 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-08 | 190 | 154 | 9 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-08 | 192 | 154 | 9 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-08 | 194 | 154 | 9 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-08 | 194 | 154 | 9 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.43e-08 | 200 | 154 | 9 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.43e-08 | 200 | 154 | 9 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-07 | 181 | 154 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.42e-07 | 182 | 154 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-07 | 183 | 154 | 8 | 7961e05c6e9964da159059c6bfb4f7e7e14308c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.75e-07 | 185 | 154 | 8 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 3.10e-07 | 188 | 154 | 8 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 3.10e-07 | 188 | 154 | 8 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.23e-07 | 189 | 154 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.36e-07 | 190 | 154 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 3.36e-07 | 190 | 154 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-07 | 193 | 154 | 8 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.94e-07 | 194 | 154 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.94e-07 | 194 | 154 | 8 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-07 | 195 | 154 | 8 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-07 | 195 | 154 | 8 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | e957f5926675f6c29208cfc3203a19dab538df38 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 2ea33ac1970791e6a601ac1e407ef32e4833792d | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 4.96e-07 | 200 | 154 | 8 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-NPM1P10|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.96e-07 | 200 | 154 | 8 | 7b3284bf0000e14f5a51e4422231e5639a184579 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.96e-07 | 200 | 154 | 8 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 1.70e-06 | 164 | 154 | 7 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 1.70e-06 | 164 | 154 | 7 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.92e-06 | 167 | 154 | 7 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.16e-06 | 170 | 154 | 7 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-06 | 172 | 154 | 7 | ba36581ae339191a12a6d3ead39eaf69d78be10e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-06 | 176 | 154 | 7 | d09e28606e2a6ed1f660898316765ca215085c18 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-06 | 178 | 154 | 7 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 3.04e-06 | 179 | 154 | 7 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-06 | 179 | 154 | 7 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.16e-06 | 180 | 154 | 7 | 708a5c89b9337e281fce4f482892a1c1766c7812 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.40e-06 | 182 | 154 | 7 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-06 | 182 | 154 | 7 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.65e-06 | 184 | 154 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.65e-06 | 184 | 154 | 7 | fa4915b0498f3069fd5ef497286445528f75187e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.68e-06 | 119 | 154 | 6 | e6f1b9f29dc8fe6b6132c7885234c385159da393 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.78e-06 | 185 | 154 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 185 | 154 | 7 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.78e-06 | 185 | 154 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.78e-06 | 185 | 154 | 7 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 3.78e-06 | 185 | 154 | 7 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 4.06e-06 | 187 | 154 | 7 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-06 | 187 | 154 | 7 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.21e-06 | 188 | 154 | 7 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 4.21e-06 | 188 | 154 | 7 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 4.21e-06 | 188 | 154 | 7 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-06 | 189 | 154 | 7 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.36e-06 | 189 | 154 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.51e-06 | 190 | 154 | 7 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.51e-06 | 190 | 154 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 191 | 154 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.67e-06 | 191 | 154 | 7 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-06 | 191 | 154 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-06 | 192 | 154 | 7 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-06 | 192 | 154 | 7 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-06 | 192 | 154 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-06 | 192 | 154 | 7 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.00e-06 | 193 | 154 | 7 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.00e-06 | 193 | 154 | 7 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-06 | 193 | 154 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.00e-06 | 193 | 154 | 7 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.00e-06 | 193 | 154 | 7 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.00e-06 | 193 | 154 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-06 | 193 | 154 | 7 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-06 | 193 | 154 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-06 | 193 | 154 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-06 | 193 | 154 | 7 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.00e-06 | 193 | 154 | 7 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-06 | 194 | 154 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.17e-06 | 194 | 154 | 7 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.35e-06 | 195 | 154 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.35e-06 | 195 | 154 | 7 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-06 | 196 | 154 | 7 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 5.53e-06 | 196 | 154 | 7 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 5.53e-06 | 196 | 154 | 7 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.53e-06 | 196 | 154 | 7 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.72e-06 | 197 | 154 | 7 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-06 | 197 | 154 | 7 | 0f9836554ace3f9d155ebafdd719aa26466ca44e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-06 | 197 | 154 | 7 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-06 | 197 | 154 | 7 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| ToppCell | ASK428-Epithelial-Type_1|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.72e-06 | 197 | 154 | 7 | 9ae6661c307791c3f0ecd3d378e3d917565e5498 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-06 | 197 | 154 | 7 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| Disease | Cafe-au-Lait Spots | 7.47e-05 | 3 | 148 | 2 | C0221263 | |
| Disease | severe acute respiratory syndrome, COVID-19 | PMS2 SLFN5 GRM7 TENM2 ANKRD54 TMED3 ADAMTS12 KIAA1217 PHF14 PDZD2 | 9.14e-05 | 447 | 148 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | coronary artery calcification | 9.66e-05 | 450 | 148 | 10 | EFO_0004723 | |
| Disease | Bipolar Disorder | 1.55e-04 | 477 | 148 | 10 | C0005586 | |
| Disease | factor VII measurement | 1.70e-04 | 55 | 148 | 4 | EFO_0004619 | |
| Disease | response to statin | 1.82e-04 | 56 | 148 | 4 | GO_0036273 | |
| Disease | mean platelet volume | JCAD ADAM19 PCDHGB3 ITGA2 IRAG1 SVEP1 ADH5 SLC6A4 FANCG UBN1 ATAD2B PADI6 MCF2L PRDM16 LRRFIP1 | 1.97e-04 | 1020 | 148 | 15 | EFO_0004584 |
| Disease | hyperinsulinism (is_marker_for) | 2.47e-04 | 5 | 148 | 2 | DOID:2018 (is_marker_for) | |
| Disease | Affective Disorders, Psychotic | 2.47e-04 | 5 | 148 | 2 | C0001723 | |
| Disease | anxiety disorder (is_implicated_in) | 3.70e-04 | 6 | 148 | 2 | DOID:2030 (is_implicated_in) | |
| Disease | bipolar disorder (is_implicated_in) | 4.11e-04 | 29 | 148 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | Manic Disorder | 4.55e-04 | 71 | 148 | 4 | C0024713 | |
| Disease | vital capacity | PDE3A GLDN ZFAT MYH7B ID4 GRM7 HIBADH TENM2 SVEP1 DST SCMH1 ATAD2B ARID5B UHRF1 AKAP7 PDZD2 | 4.96e-04 | 1236 | 148 | 16 | EFO_0004312 |
| Disease | longevity | 5.99e-04 | 284 | 148 | 7 | EFO_0004300 | |
| Disease | pulse pressure measurement | JCAD PDE3A ZFAT POGZ GRM4 PLXNB2 CEP164 ITIH1 SVEP1 ITIH3 KIAA1217 ATAD2B UHRF1 MCF2L ATP1B3 PRDM16 NDRG4 | 6.36e-04 | 1392 | 148 | 17 | EFO_0005763 |
| Disease | Manic | 6.50e-04 | 78 | 148 | 4 | C0338831 | |
| Disease | Depression, Bipolar | 6.82e-04 | 79 | 148 | 4 | C0005587 | |
| Disease | hemolytic anemia (is_implicated_in) | 6.86e-04 | 8 | 148 | 2 | DOID:583 (is_implicated_in) | |
| Disease | venous thromboembolism, factor VII measurement | 9.17e-04 | 38 | 148 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | Major Depressive Disorder | 1.46e-03 | 243 | 148 | 6 | C1269683 | |
| Disease | response to diuretic, high density lipoprotein cholesterol measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0004612, GO_0036270 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 1.60e-03 | 12 | 148 | 2 | C0403553 | |
| Disease | C-C motif chemokine 16 measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0008044 | |
| Disease | risk-taking behaviour | HIBADH TENM2 ITIH3 ITPA SLC6A4 SCMH1 ATAD2B PPA2 ARID5B PARPBP TET3 | 1.69e-03 | 764 | 148 | 11 | EFO_0008579 |
| Disease | mortality | 1.84e-03 | 173 | 148 | 5 | EFO_0004352 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 1.92e-03 | 49 | 148 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | Unipolar Depression | 2.01e-03 | 259 | 148 | 6 | C0041696 | |
| Disease | forced expiratory volume | JCAD ZFAT ADAM19 SLC44A2 ID4 PLXNB2 SVEP1 DST SCMH1 ATAD2B UHRF1 | 2.17e-03 | 789 | 148 | 11 | EFO_0004314 |
| Disease | Left ventricular noncompaction | 2.19e-03 | 14 | 148 | 2 | C1960469 | |
| Disease | Alcoholic Intoxication, Chronic | 2.39e-03 | 268 | 148 | 6 | C0001973 | |
| Disease | mean reticulocyte volume | PLIN4 ZFAT TTC7A FANCG KIAA1217 ATAD2B PPA2 AURKAIP1 USP1 PRDM16 AKAP7 | 2.39e-03 | 799 | 148 | 11 | EFO_0010701 |
| Disease | 1,3,7-trimethylurate measurement | 2.51e-03 | 15 | 148 | 2 | EFO_0021172 | |
| Disease | Drug habituation | 2.73e-03 | 115 | 148 | 4 | C0013170 | |
| Disease | Drug abuse | 2.73e-03 | 115 | 148 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.73e-03 | 115 | 148 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.73e-03 | 115 | 148 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.73e-03 | 115 | 148 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.73e-03 | 115 | 148 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.73e-03 | 115 | 148 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.73e-03 | 115 | 148 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.73e-03 | 115 | 148 | 4 | C0029231 | |
| Disease | Substance abuse problem | 2.82e-03 | 116 | 148 | 4 | C0740858 | |
| Disease | Colorectal Carcinoma | UNC13B PMS2 ADAM19 FSTL5 OBSCN ARFGEF1 FANCG CYREN SACS EXO1 | 2.94e-03 | 702 | 148 | 10 | C0009402 |
| Disease | lean body mass | 3.11e-03 | 379 | 148 | 7 | EFO_0004995 | |
| Disease | caudal middle frontal gyrus volume measurement | 3.63e-03 | 18 | 148 | 2 | EFO_0010290 | |
| Disease | sexual dimorphism measurement | ZFAT ID4 GRM4 CEP164 SLC6A4 UBN1 SCMH1 ATAD2B PPA2 AURKAIP1 TPPP3 SUCO AKAP7 | 3.87e-03 | 1106 | 148 | 13 | EFO_0021796 |
| Disease | unipolar depression, response to bupropion, mood disorder | 4.04e-03 | 19 | 148 | 2 | EFO_0003761, EFO_0004247, EFO_0006326 | |
| Disease | birth weight | 4.11e-03 | 399 | 148 | 7 | EFO_0004344 | |
| Disease | Headache | 4.12e-03 | 64 | 148 | 3 | HP_0002315 | |
| Disease | response to vaccine, cytokine measurement | 4.35e-03 | 131 | 148 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | lung cancer | 4.93e-03 | 21 | 148 | 2 | MONDO_0008903 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KNDKPEIGAQVCAEE | 136 | Q6PI77 | |
| APDARDNVKDENDGC | 551 | Q5RHP9 | |
| KKVACEGVNNDPDES | 406 | A6H8Y1 | |
| SEEAPKCSQDQGVLA | 121 | Q9H6F5 | |
| TGCIPDVQADEDALA | 416 | Q8NAG6 | |
| VQQLLEDGADPCAAD | 126 | Q6NXT1 | |
| RAKEFGATECINPQD | 231 | P11766 | |
| QDDCGITDEPQINLK | 46 | Q9P0M2 | |
| APDLCFEKVNVAGDT | 536 | Q9H013 | |
| CEADLNAKDREGDTP | 241 | Q15327 | |
| NKVGCNPNEDVAIFA | 1196 | Q9Y6D6 | |
| ELEDCEQANKLGAIN | 126 | Q86YB8 | |
| GNGCPEEDNKEASAL | 816 | P39086 | |
| PNGEAKSELCENLEA | 881 | Q14833 | |
| DALCPKREGAQNEVE | 456 | Q8NB90 | |
| VEEPLSECNLVNAGK | 151 | Q8NER5 | |
| CAAQQKGLPLDERDE | 141 | B4E2M5 | |
| CAIPNDDTLVGKADE | 276 | Q6ZMI3 | |
| FDNLLEVGPICNKED | 251 | P20711 | |
| CDGDHAAQQLTPKEA | 31 | Q96F81 | |
| GDQAVDCSKPEFEDQ | 1651 | Q5H9R4 | |
| VQCVPSEGNKTEDQD | 1496 | P58397 | |
| PDIVLCGNKSDLEDQ | 126 | P51159 | |
| KAENPQCLLGDFVTE | 316 | Q15042 | |
| DDVCRILVGNKNDDP | 111 | Q15286 | |
| GQNSRDPFCKAIEEV | 291 | Q9NWS1 | |
| QVNGCPADAEKDRLI | 1606 | Q9HCM3 | |
| EKACEQPALAGADNP | 76 | Q9BWK5 | |
| VNCNPADVGQQLEDK | 161 | Q6TGC4 | |
| LLPKEANCEGFIEEA | 256 | Q8N4N3 | |
| DDKDAAAICQPSAGV | 301 | P43304 | |
| INQEPKDSSPAEECD | 1806 | Q16787 | |
| NKAVGDKLPECEADD | 76 | P00738 | |
| QKEDTLCFNINEEPG | 681 | P19827 | |
| NNLEEIKFCLDPAEG | 4976 | Q03001 | |
| ATALQAEENEVGCPE | 4601 | Q8NDA2 | |
| ECSNNEKLEPGSDVE | 1336 | Q9ULI0 | |
| LAQPQGFCEDIKLDD | 436 | Q9P266 | |
| KICDLNANTESEVPG | 436 | Q9NYF5 | |
| GAFDPIQEIADICEK | 351 | Q99259 | |
| DEPSEKDALQCGRNI | 146 | O00757 | |
| LLENGKTNGDPDCEA | 736 | Q9Y6F6 | |
| DLDAVEAQIGCKLPD | 126 | Q9UK99 | |
| LQEAEEGVEAANAKC | 1446 | A7E2Y1 | |
| DEGVDAIPVKVLNCD | 1471 | O15031 | |
| AQDGDKLLEGDECAP | 16 | Q9H2R5 | |
| PQDVCGAEESKGNLE | 476 | O15018 | |
| QCKEAAAAEEEEAAP | 91 | Q14432 | |
| ANEKVEDINGCPRSQ | 121 | Q8IVL0 | |
| QFLEEQKCVPASGEL | 1131 | Q8TDM6 | |
| GFLDPLATDNQKECE | 131 | Q6ZU52 | |
| LPQESLKDAGQCEVD | 171 | Q9HB14 | |
| ATPEEKEQGAAFNCE | 486 | O15287 | |
| FEEAVQCPDIGEANA | 66 | Q9NVS9 | |
| ACAPQGQLLVADAKD | 96 | P0CG21 | |
| CKVQIDISDENDNAP | 331 | Q9Y5G1 | |
| KAENAAPQDLLCDEA | 771 | Q9Y5G1 | |
| KAAEAAADEPALCLQ | 51 | P47928 | |
| LCGDPQEKVAEEAAE | 261 | Q9H579 | |
| TDKAGDISCNADINP | 1011 | P17301 | |
| GNDVCPVTFLKNDDV | 181 | Q8TCD6 | |
| ELCPNQDGIFKETDA | 386 | O94880 | |
| QDEVCPKAEGDEVQR | 486 | Q8N475 | |
| GLQVDAEAACAEQAP | 96 | Q5VST9 | |
| GQPVCELAASKDLEE | 126 | P78367 | |
| ANDALSPEEQEECKN | 696 | A6NKT7 | |
| VDGNKNSPADTCVEE | 336 | Q9H7U1 | |
| FDCLDPEVLNGQVSK | 911 | Q9C0G6 | |
| AADKDGNVTCEREVP | 71 | Q16658 | |
| KELNEAVAALCGDQE | 2266 | P49454 | |
| AEEEQEAALCAQGPK | 61 | Q96MA1 | |
| VQDNEGCPVEALVKD | 711 | P21333 | |
| NAFCGDEKNKEAPQD | 646 | Q9P278 | |
| TAQEEGIFECADPKL | 731 | Q6NUI2 | |
| GEQFVEEALEKSPCQ | 226 | O14879 | |
| LPLDNEDQCKTDGID | 146 | O43303 | |
| QPVDKCQSQDGAEAA | 481 | O15068 | |
| QGEPDEISIQKCQEA | 46 | Q9BY32 | |
| VKEVPEGNSKDLDAC | 156 | Q9UIH9 | |
| GEAKTELCENVDPNS | 886 | Q14831 | |
| DKQGPEECDAVALLS | 126 | Q8TB03 | |
| NKGVAEVLQDGDCPA | 146 | Q8IWA5 | |
| VPAEDLCNEGQIASD | 336 | Q96QF7 | |
| HQEEKVQECEGEPGV | 5286 | Q8NDH2 | |
| QLDEETPKVCQFGAL | 3981 | Q9NZJ4 | |
| GEGKDNFVQCPVEAL | 156 | Q9UK39 | |
| ELQEQAGCEAPEAAA | 86 | Q9UBU6 | |
| GQCIIHAENDEKPEG | 311 | P02771 | |
| QTENPLECQDKGEEE | 386 | P02771 | |
| VKDCVDIEVFPAGEN | 331 | Q32MZ4 | |
| VSCPGEEENQATEDK | 221 | O75807 | |
| AGVQCKAALDEQFEP | 41 | P15428 | |
| VLGQEKQDGFPEQCI | 256 | Q5VVY1 | |
| DCPAAVVDDNEKNLS | 181 | Q9NQ35 | |
| VDPQIDDIVKAVGNC | 371 | Q8NBR6 | |
| DCFRLIEKAQQAPEG | 1216 | Q96Q06 | |
| QGDQQVCAEEADPEL | 181 | Q8IYJ3 | |
| KPVLNGVDQVAAECA | 1031 | P26640 | |
| ANDALSPEEQEECKN | 696 | Q7Z3J3 | |
| KGEQCNIVPDNVDDI | 411 | Q9HCB6 | |
| EQLKEESEGEQFPGC | 741 | Q9HCB6 | |
| LKEAQEGCEPQAFAE | 951 | Q6ZMQ8 | |
| GKEDNNTVVLEPDKC | 41 | Q8NI08 | |
| LEDCEEAFLKNPEGK | 376 | Q7Z494 | |
| KDDALCFNIDEAPGT | 661 | Q06033 | |
| VGDAAVQELARNCPE | 206 | Q9H469 | |
| PLATEGAECLNVDDQ | 931 | Q7Z3K3 | |
| QCPGLASEKQEDVEE | 1106 | Q9HAZ2 | |
| QEGTDNEDPVVCLDK | 1426 | Q5T5P2 | |
| EVLGCAKENVDPDSL | 256 | Q7Z7L1 | |
| NKDNEGDGLVDCLDP | 851 | Q9NT68 | |
| NAPAEDGVVECNSKL | 236 | Q9ULP0 | |
| DKSTNCFGDNDPIDV | 156 | Q9H2U2 | |
| NVGVQAAVCKDVEAP | 551 | Q4LDE5 | |
| EAEEDIFNKPECGRV | 826 | Q9UQ84 | |
| DSAEIQPIGNCEKNG | 106 | Q96GD3 | |
| FPDACKEFQDAGEQV | 71 | P31937 | |
| DEGVADAPQIQCKNV | 116 | Q9NWT8 | |
| ENESICDEFAPNLKG | 236 | Q14865 | |
| ACRQAQQPLGIEDKD | 436 | Q9UPV0 | |
| EQKNLTVCPDGALFE | 121 | P54709 | |
| DVGEPNNIATLEDCA | 166 | Q9ULY5 | |
| PNDGCLNFIEENDEV | 86 | P62266 | |
| LPNGAESLKDFCQED | 956 | Q9UNS1 | |
| LLCGEDDDKVQNAAA | 811 | Q8IWX7 | |
| KVAEQCEPAESQPEA | 426 | P82094 | |
| EENGIDCNQVDKPSD | 151 | Q5T6F2 | |
| QGVNALKEEACPGDT | 526 | Q9P243 | |
| EESATGEKQDCINQP | 841 | Q13129 | |
| EDISQGCPESKNEAE | 121 | Q7Z699 | |
| LQDGDVDEECPAQAQ | 256 | Q9H9D4 | |
| AFQDCEKVLELEPGN | 261 | Q07617 | |
| GAELTFELPDNAKQC | 26 | Q9Y3Q3 | |
| PLEVTGQAEKEAACE | 316 | O14795 | |
| CDVGEALDASAPIEQ | 171 | Q9UBS9 | |
| EDNRCVGKIPEDEQL | 1096 | O43151 | |
| KICPGENQAAEDELR | 651 | P54278 | |
| FDAICQLVAGKEPAN | 96 | Q9BW30 | |
| QEILGPEAQADEAGC | 91 | P37275 | |
| PEAQADEAGCTVKDD | 96 | P37275 | |
| NCFAPINDQEGAEAK | 511 | Q96T88 | |
| KEEAGAGEQHQDCEP | 26 | Q9NPG3 | |
| IPVDQQDDDKGNCED | 196 | P17010 | |
| EGDNLYCPKDNIEEA | 331 | Q9ULT0 | |
| NLGDEENFCATVPKD | 921 | Q14139 | |
| KNGPQEKDCDLVDLD | 381 | Q9HB21 | |
| EDGEDCQENGVLQKV | 16 | P31645 | |
| AQSFGAVCKEPQEEV | 16 | Q9UHF0 | |
| LGACDPEDDESNKLA | 746 | Q9H4I2 | |
| LAEQDPDELNKACSF | 126 | Q6PJE2 | |
| DSEIAKQAVCDPGNI | 1191 | Q92547 | |
| ELCDAAGRPDQEVAQ | 426 | P51784 | |
| VLQAVDAGDPAVEAC | 526 | Q9BQ70 | |
| DVDTNFPECVVDAGK | 6 | Q08AF3 | |
| GVKGQSKENECDPEE | 366 | O94782 | |
| NRNPEDDGCLLKQES | 211 | Q8N7P7 | |
| ANEDSVPENTCKEGL | 721 | Q7Z3T8 | |
| AACGSPEEVLQAEQE | 206 | Q9UJK0 | |
| DPENLSEEKCGIIDQ | 511 | Q8NDX2 | |
| ISDCEKQALAQSEPG | 681 | Q5FWF4 | |
| NNDLQDDGVKILCDA | 966 | Q86W24 |